Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Accelerating Therapeutics for COVID-19

This webinar will explain lessons learned from preparing for and responding to viral outbreaks such as H5N1 and pH1N1 influenza and discuss how insights from model-informed drug development approaches can spur access to medicines for patients.

Speaker(s): Dr. Dan Hartman - Director of Integrated Development - Bill & Melinda Gates Foundation,
Dr. Steven Kern - Deputy Director of Quantitative Sciences - Bill & Melinda Gates Foundation,
Dr. Craig Rayner - President of Integrated Drug Development - Certara
Dr. Fran Brown - SVP of Integrated Drug Development - Certara
Solution: Clinical Pharmacology Strategy, Evidence and Access, PBPK Modeling & Simulation, PK/PD Modeling & Simulation
Therapeutic Area: Infectious Disease
More Info

Certara’s Best of the Blog 2019

A selection of short essays from our blog, written to empower our clients with modeling and simulation (M&S), regulatory science, and real-world value assessment solutions to help them solve the toughest drug development problems. In the Best of the Blog, Certara’s scientists and regulatory experts share their learnings, technological advances, and thought leadership.

Therapeutic Area: Central Nervous System, Infectious Disease, Oncology/Hematology, Pediatrics, Rare/Orphan Disease
More Info

Prescription Drug Pricing: “The Times They Are A-Changin”

“Come senators, congressmen Please heed the call Don’t stand in the doorway Don’t block up the hall For he that gets hurt Will be he who has stalled” Bob Dylan recorded his iconic “The Times They Are a Changin’” in 1963; the song was released on the 1964 album by the same name. One of […]

Author(s): Ulrich Neumann
More Info